Your browser doesn't support javascript.
loading
Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
Mukhlid Yousif; Said Rachida; Setshaba Taukobong; Nkosenhle Ndlovu; Chinwe Iwu-Jaja; Wayne Howard; Shelina Moonsamy; Nompilo Mhlambi; Sipho Gwala; Joshua Levy; Kristian Andersen; Cathrine Scheepers; Anne von Gottberg; Nicole I Wolter; Arshad Ismail; Melinda Suchard; Kerrigan McCarthy.
  • Mukhlid Yousif; National Institute for Communicable Diseases, South Africa
  • Said Rachida; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Setshaba Taukobong; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Nkosenhle Ndlovu; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Chinwe Iwu-Jaja; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Wayne Howard; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Shelina Moonsamy; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Nompilo Mhlambi; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Sipho Gwala; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, South Africa
  • Joshua Levy; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA
  • Kristian Andersen; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA
  • Cathrine Scheepers; SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Anne von Gottberg; entre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, South Africa
  • Nicole I Wolter; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, South Africa
  • Arshad Ismail; Sequencing Core Facility, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa.
  • Melinda Suchard; Department of Chemical Pathology, School of Pathology, University of the Witwatersrand, Johannesburg.
  • Kerrigan McCarthy; Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
Preprint En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22283506
The use of wastewater for SARS-CoV-2 surveillance is a useful complementary tool to clinical surveillance. The aims of this study were to characterize SARS-CoV-2 from wastewater samples, and to identify variants of concern present in samples collected from wastewater treatment plants in South African urban metros from April 2021 to January 2022. A total of 325 samples were collected from 15 wastewater treatment plants. Nucleic acids were extracted from concentrated samples, and subjected to amplicon-based whole genome sequencing. To identify variants of concerns and lineages, we used the Freyja tool (https//github.com/andersen-lab/Freyja), which assigns each sample with the prevalence of each variant present. We also used signature mutation analysis to identify variants in each wastewater treatment site. A heatmap was generated to identify patterns of emerging mutations in the spike gene using Excel conditional formatting. Using the Freyja tool, the Beta variant was detected and became predominate from April to June 2021 followed by the Delta variant and lastly the Omicron variant. Our heatmap approach was able to identify a pattern during the changes of predominate variant in wastewater with the emergence of mutations and the loss of others. In conclusion, sequencing of SARS-CoV-2 from wastewater largely corresponded with sequencing from clinical specimens. Our heatmap has the potential to detect new variants prior to emergence in clinical samples and this may be particularly useful during times of low disease incidence between waves, when few numbers of positive clinical samples are collected and submitted for testing. A limitation of wastewater sequencing is that it is not possible to identify new variants, as variants are classified based on known mutations in clinical strains.

cc_by_nc_nd
...